Alterations of the genes involved in the PI3K and estrogen-receptor pathways influence outcome in human epidermal growth factor receptor 2-positive and hormone receptor-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy

BMC cancer

Volumn 13, Issue , 2013, Pages 241-

  Takada, Mamoru ^a   Higuchi, Toru ^a   Tozuka, Katsunori ^a   Takei, Hiroyuki ^a   Haruta, Masayuki ^a   Watanabe, Junko ^a   Kasai, Fumio ^a   Inoue, Kenichi ^a   Kurosumi, Masafumi ^a   Miyazaki, Masaru ^a   Sato Otsubo, Aiko ^a   Ogawa, Seishi ^a   Kaneko, Yasuhiko ^a  

^a SAITAMA CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; ERBB2 PROTEIN, HUMAN; ESTROGEN RECEPTOR; FLUOROURACIL; MONOCLONAL ANTIBODY; PACLITAXEL; PHOSPHATIDYLINOSITOL 3 KINASE; PROGESTERONE RECEPTOR; TRASTUZUMAB;

ADJUVANT CHEMOTHERAPY; BREAST NEOPLASMS; CHROMOSOME ABERRATION; DISEASE FREE SURVIVAL; DNA MICROARRAY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DOSAGE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; METABOLISM; NEOADJUVANT THERAPY; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL RATE;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHROMOSOME ABERRATIONS; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; EPIRUBICIN; FEMALE; FLUOROURACIL; GENE DOSAGE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KAPLAN-MEIER ESTIMATE; NEOADJUVANT THERAPY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PACLITAXEL; PHOSPHATIDYLINOSITOL 3-KINASES; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SIGNAL TRANSDUCTION; SURVIVAL RATE; TRASTUZUMAB;

EID: 84886753482     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-241     Document Type: Article

References (0)